Department of Clinical Epidemiology & Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada.
Syst Rev. 2013 Aug 8;2:64. doi: 10.1186/2046-4053-2-64.
The role of vitamin D in management of depression is unclear. Results from observational and emerging randomized controlled trials (RCTs) investigating the efficacy of vitamin D in depression lack consistency - with some suggesting a positive association while others show a negative or inconclusive association.
METHODS/DESIGN: The primary aim of this study is to conduct a systematic review of RCTs to assess the effect of oral vitamin D supplementation versus placebo on depression symptoms measured by scales and the proportion of patients with symptomatic improvement according to the authors' original definition. Secondary aims include assessing the change in quality of life, adverse events and treatment discontinuation. We will conduct the systematic review and meta-analysis according to the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions. We will search the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 to present), EMBASE (1980 to present), CINAHL (1982 to present), PsychINFO (1967 to present) and ClinicalTrials.gov. Unpublished work will be identified by searching two major conferences: the International Vitamin Conference, the Anxiety Disorders and Depression Conference, while grey literature will be acquired by contacting authors of included studies. We will use the random-effects meta-analysis to synthesize the data by pooling the results of included studies.
The results of this systematic review will be helpful in clarifying the efficacy of vitamin D supplementation and providing evidence to establish guidelines for implementation of vitamin D for depression in general practice and other relevant settings.
Unique identifier: CRD42013003849.
维生素 D 在抑郁症管理中的作用尚不清楚。观察性和新兴的随机对照试验(RCT)的结果表明,维生素 D 治疗抑郁症的疗效不一致 - 一些研究表明存在正相关,而另一些研究则显示出负相关或不确定的关联。
方法/设计:本研究的主要目的是对 RCT 进行系统评价,以评估口服维生素 D 补充剂与安慰剂相比对抑郁症症状(通过量表测量)和根据作者原始定义有症状改善的患者比例的影响。次要目标包括评估生活质量的变化、不良事件和治疗中断。我们将根据 Cochrane 干预系统评价手册的建议进行系统评价和荟萃分析。我们将搜索 Cochrane 对照试验中心注册库(CENTRAL)、MEDLINE(1966 年至今)、EMBASE(1980 年至今)、CINAHL(1982 年至今)、PsychINFO(1967 年至今)和 ClinicalTrials.gov。未发表的工作将通过搜索两个主要会议来确定:国际维生素会议、焦虑障碍和抑郁症会议,同时通过联系纳入研究的作者获取灰色文献。我们将使用随机效应荟萃分析通过合并纳入研究的结果来综合数据。
本系统评价的结果将有助于澄清维生素 D 补充剂的疗效,并提供证据为在一般实践和其他相关环境中实施维生素 D 治疗抑郁症制定指南。
独特标识符:CRD42013003849。